Prenylamine Lactate
Basic information
- CAS
69-43-2- Standard SMILES
CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1.CC(O)C(=O)O- InChIKey
QPOFIDVRLWJICD-UHFFFAOYSA-N- Molecular formula
- C27H33NO3
- Average molar mass
- 419.6 g/mol
- Monoisotopic mass
- 419.24604391
Overview
prenylamine compounded with lactic acid; not a salt
Names & identifiers
- Preferred name
- Prenylamine Lactate
- IUPAC
- 3,3-diphenyl-N-(1-phenylpropan-2-yl)propan-1-amine;2-hydroxypropanoic acid
- English name
- N-(3,3-Diphenylpropyl)-alpha-methylphenethylamin lactate salt
- Molecular formula
- C28H35NO2
- Molecular weight
- 417.58
Names & synonyms
Prenylamine lactate69-43-26J3J6SXI7VDTXCID3025544RefChem:175891200-705-5DTXSID5045544SegontinCorontinPrenylamine lactate [JAN]AngorminCoredamin
Show more names
crepasin
IncoranIrrorinPlactaminReocorinSeccidinSedolatanAgozolRoinin
Database identifiers
- CAS
69-43-2- PubChem CID
- 65557
- ChEMBL
CHEMBL1367944- UNII
- 6J3J6SXI7V
- EC Number
- 200-705-5
Properties
Computed structural properties
- Topological polar surface area
- 69.6 Ų
- Hydrogen bond donors
- 3
- Hydrogen bond acceptors
- 4
- Rotatable bonds
- 9
- Heavy atoms
- 31
- Formal charge
- 0
- Complexity
- 375
Physicochemical properties
- Melting point
- 140 · 140-142°
- storage temp.
- 2 · 2-8°C
- FDA UNII
- 6 J3J6SXI7V · 6J3J6SXI7V
- Hazard Codes
- Xn
- Risk Statements
- 20 · 20/21/22-36/37/38
- Safety Statements
- 26 · 26-36
- RTECS
- 6490000 · SH6490000
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Hazard information
Other Safety InformationIMAP assessments - Propanoic acid, 2-hydroxy-, compound with N-(1-methyl-2-phenylethyl)-.gamma.-phenylbenzenepropanamine (1:1): Human health tier I assessment
Safety data
- rtecs
- SH6490000
- risk_code
- 20/21/22-36/37/38
- hazard_code
- Xn
- safety_code
- 26-36
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
Drugs used to cause dilation of the blood vessels.
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.
Applications
UsesVasodilator (coronary).
Suppliers
Loading…
Open inquiries
Loading…
Related reactions
0 records
No reaction records under the current filter.
Compound notes
Loading…